Nexentis Technologies Subsidiary MitoCareX Bio Enters Research Agreement With Boltz To Accelerate Identification Of Novel Small-Molecule Proteins Of Interest Using AI Platforms

Loading news article.

Nexentis Technologies Subsidiary MitoCareX Bio Enters Research Agreement With Boltz To Accelerate Identification Of Novel Small-Molecule Proteins Of Interest Using AI Platforms | WAPE

Nexentis Technologies Subsidiary MitoCareX Bio Enters Research Agreement With Boltz To Accelerate Identification Of Novel Small-Molecule Proteins Of Interest Using AI Platforms

Article summary

Related companies

Comments —